ConductScience.org, home

Paper41929322

Plasma pTau217 as a Prognostic, Monitoring, and Risk-Stratification Biomarker of Clinical Progression in Lewy Body Disease.

Lorkiewicz SA and 17 others. medRxiv, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Plasma pTau217 as a Prognostic, Monitoring, and Risk-Stratification Biomarker of Clinical Progression in Lewy Body Disease. Papers, record 41929322. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41929322

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Plasma pTau217 as a Prognostic, Monitoring, and Risk-Stratification Biomarker of Clinical Progression in Lewy Body Disease.
PubMed
Journal
medRxiv
PubMed
Year
2026
PubMed
Publication types
Journal Article, Preprint
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-22
PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lorkiewicz SAS Ahttps://orcid.org/0000-0002-0560-5979
2Abdelnour CC
3Bolen MMhttps://orcid.org/0000-0003-1973-3784
4Smith AMA M
5Shahid-Besanti MMhttps://orcid.org/0000-0002-8515-3238
6Hemachandra DD
7Müller-Oehring EME Mhttps://orcid.org/0000-0001-8908-4471
8Siddiqui NN
9Montoliu-Gaya LL
10Arslan BB
11Ashton NJN Jhttps://orcid.org/0000-0002-3579-8804
12Wilson ENE N
13Tian LL
14Andreasson KIK Ihttps://orcid.org/0000-0001-8391-4155
15Mormino ECE C
16Henderson VWV W
17Zetterberg HH
18Poston KLK Lhttps://orcid.org/0000-0003-3424-7143

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants9

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AG081144NIA NIH HHSUnited StatesR01AG081144PubMedNIH RePORTER
U19 AG065156NIA NIH HHSUnited StatesU19AG065156PubMedNIH RePORTER
R01 NS107513NINDS NIH HHSUnited StatesR01NS107513PubMedNIH RePORTER
U01 DK140939NIDDK NIH HHSUnited StatesU01DK140939PubMedNIH RePORTER
R21 NS132101NINDS NIH HHSUnited StatesR21NS132101PubMedNIH RePORTER
R01 AG089169NIA NIH HHSUnited StatesR01AG089169PubMedNIH RePORTER
R01 NS115114NINDS NIH HHSUnited StatesR01NS115114PubMedNIH RePORTER
P30 AG066515NIA NIH HHSUnited StatesP30AG066515PubMedNIH RePORTER
R21 AG096957NIA NIH HHSUnited StatesR21AG096957PubMedNIH RePORTER

Download CSV of grants

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128592453Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.Neurology2017https://conductscience.org/library/papers/28592453PubMed
218999346Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies.Neuropsychology2008https://conductscience.org/library/papers/18999346PubMed
341240920Diagnostic and other biomarkers of dementia with Lewy bodies: from research to clinical settings.Lancet Neurol2025https://conductscience.org/library/papers/41240920PubMed
441963316Plasma phosphorylated tau 217 detects amyloid-β in neuronal synuclein disease.NPJ Parkinsons Dis2026https://conductscience.org/library/papers/41963316PubMed
539583647Performance of plasma p-tau217 and NfL in an unselected memory clinic setting.Alzheimers Dement (Amst)2024https://conductscience.org/library/papers/39583647PubMed
628655337Long-term cognitive outcome of Alzheimer's disease and dementia with Lewy bodies: dual disease is worse.Alzheimers Res Ther2017https://conductscience.org/library/papers/28655337PubMed
740853684Concurrent Changes in Plasma Phosphorylated Tau 217, Tau PET, and Cognition in Preclinical Alzheimer Disease.JAMA Neurol2025https://conductscience.org/library/papers/40853684PubMed
831660655Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases.Mov Disord2020https://conductscience.org/library/papers/31660655PubMed
922658286Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer's disease clinical trials.Alzheimers Dement2013https://conductscience.org/library/papers/22658286PubMed
1033285015Plasma Phospho-Tau Identifies Alzheimer's Co-Pathology in Patients with Lewy Body Disease.Mov Disord2021https://conductscience.org/library/papers/33285015PubMed
1140155777Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials.Nat Aging2025https://conductscience.org/library/papers/40155777PubMed
1239742695The effect of Amyloid and Tau Co-pathology on disease progression in Lewy body dementia: A systematic review.Parkinsonism Relat Disord2025https://conductscience.org/library/papers/39742695PubMed
1336511519Illusory Responses across the Lewy Body Disease Spectrum.Ann Neurol2023https://conductscience.org/library/papers/36511519PubMed
1434151807Plasma Neurofilament Light Chain Predicts Cognitive Progression in Prodromal and Clinical Dementia with Lewy Bodies.J Alzheimers Dis2021https://conductscience.org/library/papers/34151807PubMed
1541402627Plasma p-Tau217 and GFAP predict widespread cognitive decline in Alzheimer's disease.J Neurol2025https://conductscience.org/library/papers/41402627PubMed
1621606904Factor structure of the National Alzheimer's Coordinating Centers uniform dataset neuropsychological battery: an evaluation of invariance between and within groups over time.Alzheimer Dis Assoc Disord2011https://conductscience.org/library/papers/21606904PubMed
1732063246The Uniform Dataset 3.0 Neuropsychological Battery: Factor Structure, Invariance Testing, and Demographically Adjusted Factor Score Calculation.J Int Neuropsychol Soc2020https://conductscience.org/library/papers/32063246PubMed
1833949133Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau.EMBO Mol Med2021https://conductscience.org/library/papers/33949133PubMed
1941319153Combined use of plasma p-tau217, NfL, and GFAP predicts domain-specific cognitive decline in cognitively unimpaired and MCI individuals.Alzheimers Dement2025https://conductscience.org/library/papers/41319153PubMed
2041312760Serum p-tau217 Is a Prognostic Indicator of Cognitive Impairment in Idiopathic REM Sleep Behavior Disorder.Ann Neurol2026https://conductscience.org/library/papers/41312760PubMed

See all 49 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41929322

GET https://conductscience.org/api/papers/v1/41929322/references?page=2